Qoria Limited (ASX:QOR)
Australia flag Australia · Delayed Price · Currency is AUD
0.6000
+0.0300 (5.26%)
Jul 31, 2025, 4:10 PM AEST

CTI BioPharma Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
Net Income
--54.77-86.72-64.02-21.93
Upgrade
Depreciation & Amortization
-31.5224.0110.772.61
Upgrade
Stock-Based Compensation
-20.1338.8919.491.9
Upgrade
Other Operating Activities
-5.72-3.941.450.16
Upgrade
Change in Accounts Receivable
--8-2.795.6-5.94
Upgrade
Change in Inventory
----0.43-0.12
Upgrade
Change in Accounts Payable
-1.587.7-6.382.9
Upgrade
Change in Unearned Revenue
-14.64.91-4.434.27
Upgrade
Change in Other Net Operating Assets
-3.13-2.292.090.68
Upgrade
Operating Cash Flow
-6.77-23.64-37.27-15.48
Upgrade
Capital Expenditures
--5.97-4.16-1.33-2.01
Upgrade
Cash Acquisitions
--1.91-19.86-142.360.03
Upgrade
Sale (Purchase) of Intangibles
--19.55-1.81--
Upgrade
Investment in Securities
-1.970.14--
Upgrade
Investing Cash Flow
--25.47-25.7-143.69-1.98
Upgrade
Long-Term Debt Issued
-32.955.143.520.44
Upgrade
Total Debt Issued
-32.955.143.520.44
Upgrade
Long-Term Debt Repaid
--11.42-3.72-4.38-1.78
Upgrade
Net Debt Issued (Repaid)
-21.531.42-0.86-1.34
Upgrade
Issuance of Common Stock
-0.1419.56179.7347.78
Upgrade
Financing Cash Flow
-21.6720.98178.8746.45
Upgrade
Foreign Exchange Rate Adjustments
--0.22.23-0.10.14
Upgrade
Net Cash Flow
-2.77-26.13-2.1929.13
Upgrade
Free Cash Flow
-0.8-27.8-38.6-17.49
Upgrade
Free Cash Flow Margin
-0.80%-33.72%-85.42%-132.30%
Upgrade
Free Cash Flow Per Share
-0.00-0.03-0.06-0.05
Upgrade
Cash Interest Paid
-2.250.880.390.15
Upgrade
Cash Income Tax Paid
--0.52--
Upgrade
Levered Free Cash Flow
--6.9622.039.85-5.64
Upgrade
Unlevered Free Cash Flow
--2.2325.3911.16-5.58
Upgrade
Change in Net Working Capital
--3.9-24.09-19.88-5.58
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.